Breaking News Instant updates and real-time market news.

INGN

Inogen

$213.80

0.24 (0.11%)

20:47
08/07/18
08/07
20:47
08/07/18
20:47

Inogen price target raised to $245 from $235 at Piper Jaffray

Piper Jaffray analyst JP McKim raised his price target on Inogen to $245 and kept his Overweight rating after its "stellar" Q2 earnings and raised FY18 guidance. The analyst notes that the beat was "broad-based", featuring outperformance in DTC, BTB, and International segments, while also pointing to higher than expected gross margins in spite of the price discounting and higher operating expenditure than expected. McKim believes that Inogen's growth is "firing on all cylinders", with the company looking to expand its hiring pace and also holding discussions about a next-generation product.

  • 07

    Aug

  • 14

    Aug

  • 15

    Aug

  • 27

    Aug

INGN Inogen
$213.80

0.24 (0.11%)

06/06/18
KEYB
06/06/18
INITIATION
KEYB
Sector Weight
Inogen initiated with a Sector Weight at KeyBanc
KeyBanc analyst Matt Mishan started Inogen with a Sector Weigh rating saying the current valuation does not reflect potential risks to the long-term model.
07/09/18
PIPR
07/09/18
NO CHANGE
Target $235
PIPR
Overweight
Inogen price target raised to $235 from $190 at Piper Jaffray
Piper Jaffray analyst JP McKim raised his price target for Inogen to $235 and says investors should own the stock into the company's Q2 results. Inogen every 18 months does a price elasticity of demand check by offering certain discounts in certain states to see what the volume of demand is like at a lower price, McKim tells investors in a research note. The analyst's channel checks indicate this was done during Q2 across 10 states, mainly in the DTC business. Feedback suggests there is clear demand for the product at lower prices and that there is no need for Inogen to permanently drop price at this time, McKim adds. He believes the company's volumes can grow over 60% in Q2, and $87M in sales is his updated forecast. The analyst adds that Q2 sales north of $90M "would not be farfetched." McKim keeps an Overweight rating on Inogen.
07/12/18
PIPR
07/12/18
NO CHANGE
Target $235
PIPR
Overweight
CMS proposal neutral for Inogen shares, says Piper Jaffray
Piper Jaffray analyst JP McKim's initial read on the Centers for Medicare & Medicaid Services' 368-page proposal to modernize and drive innovation in durable medical equipment, which included commentary on competitive bidding and oxygen, as neutral for shares of Inogen. Seemingly, CMS is not ready for 2019 competitive bidding and will let current bid contracts expire, McKim tells investors in a research note. This does not mean competitive bidding is going away, it just means that CMS needed something to fill the gap until they decide how to structure the next round, the analyst adds. He still likes Inogen shares into the Q2 earnings report, and recommends buying the stock more aggressive should the CMS proposal "cause any confusion in the market." McKim keeps an Overweight rating on the shares with a $235 price target.
07/16/18
PIPR
07/16/18
NO CHANGE
Target $235
PIPR
Overweight
Respironics go direct move negative headline for Inogen, says Piper Jaffray
Respironics recently updated its website to allow patients to buy direct from the company or to find the nearest durable medical equipment supplier that carries SimplyGo, Piper Jaffray analyst JP McKim tells investors in a research note. This is the first move by a competitor to go more direct and a negative headline to Inogen shares, the analyst contends. He notes the pricing is the same as Inogen's at $2,495 but also offers a monthly payment, assuming the patient qualifies for a loan. McKim believes that Inogen still has the advantage with years of direct-to-consumer advertising and a clear brand advantage. Nonetheless, competition "is seemingly heating up," he writes. However, the analyst sees room for multiple players and keeps an Overweight rating on Inogen with a $235 price target.

TODAY'S FREE FLY STORIES

ROKU

Roku

$40.62

-0.23 (-0.56%)

, AAPL

Apple

$177.31

0.21 (0.12%)

15:38
11/21/18
11/21
15:38
11/21/18
15:38
Hot Stocks
Roku slips as Apple reportedly held talks over TV 'dongle' »

Roku (ROKU) shares were…

ROKU

Roku

$40.62

-0.23 (-0.56%)

AAPL

Apple

$177.31

0.21 (0.12%)

AMZN

Amazon.com

$1,522.82

27.22 (1.82%)

GOOG

Alphabet

$1,043.32

17.32 (1.69%)

GOOGL

Alphabet Class A

$1,049.65

18.43 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

PDD

Pinduoduo

$23.78

0.63 (2.72%)

15:30
11/21/18
11/21
15:30
11/21/18
15:30
Options
Put sellers in Pinduoduo as shares extend gains »

Put sellers in Pinduoduo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.75

0.65 (0.37%)

, AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

15:29
11/21/18
11/21
15:29
11/21/18
15:29
Periodicals
Apple weighed new connected TV 'dongle,' Information reports »

Apple (AAPL) has held…

AAPL

Apple

$177.75

0.65 (0.37%)

AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

GOOG

Alphabet

$1,044.26

18.26 (1.78%)

GOOGL

Alphabet Class A

$1,050.29

19.07 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

TSRO

Tesaro

$43.63

1.15 (2.71%)

15:25
11/21/18
11/21
15:25
11/21/18
15:25
Options
TESARO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

GME

GameStop

$13.72

1.42 (11.54%)

15:22
11/21/18
11/21
15:22
11/21/18
15:22
Recommendations
GameStop analyst commentary  »

GameStop sale of Spring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

ESRX

Express Scripts

$95.91

0.61 (0.64%)

, CI

Cigna

$210.99

3.09 (1.49%)

15:18
11/21/18
11/21
15:18
11/21/18
15:18
Hot Stocks
NYDFS to hold hearing on Cigna deal for Express Scripts on December 7 »

The New York State…

ESRX

Express Scripts

$95.91

0.61 (0.64%)

CI

Cigna

$210.99

3.09 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/21/18
11/21
15:17
11/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/21/18
11/21
15:16
11/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$66.17

0.75 (1.15%)

15:14
11/21/18
11/21
15:14
11/21/18
15:14
Recommendations
Nu Skin analyst commentary  »

Nu Skin pullback a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$5.38

1.08 (25.12%)

15:10
11/21/18
11/21
15:10
11/21/18
15:10
Options
Call buyers in Qudian as shares rally 24% »

Call buyers in Qudian as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HDSN

Hudson Technologies

$1.13

0.04 (3.67%)

15:04
11/21/18
11/21
15:04
11/21/18
15:04
Options
Hudson Technologies options imply 31.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.52

0.5 (3.84%)

15:00
11/21/18
11/21
15:00
11/21/18
15:00
Options
Size Reverse/Conversion trade in Barrick Gold suggests stock replacement »

Size Reverse/Conversion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$18.87

0.37 (2.00%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Options
Active trading in VanEck Vectors Oil Services 20-strike calls »

Active trading in VanEck…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,529.99

34.39 (2.30%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Periodicals
NYC officials say half of Queens Amazon jobs won't be in tech, WSJ says »

New York City officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

SQM

SQM

$43.70

1.825 (4.36%)

14:49
11/21/18
11/21
14:49
11/21/18
14:49
Options
SQM options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
11/21/18
11/21
14:45
11/21/18
14:45
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CBFV

CB Financial Services

$25.79

(0.00%)

14:42
11/21/18
11/21
14:42
11/21/18
14:42
Hot Stocks
CB Financial Services increases dividend by 4.5% to 23c per share »

CB Financial Services,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$32.94

4.87 (17.35%)

14:28
11/21/18
11/21
14:28
11/21/18
14:28
Hot Stocks
CD&R Group to buy additional shares in Beacon Roofing »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NTN

NTN Buzztime

$2.70

-0.1 (-3.57%)

14:26
11/21/18
11/21
14:26
11/21/18
14:26
Hot Stocks
Northstar reports 10.33% stake in NTN Buzztime »

On November 21, Northstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:23
11/21/18
11/21
14:23
11/21/18
14:23
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a podcast »

The Commodity Futures…

RHHBY

Roche

$0.00

(0.00%)

, ABBV

AbbVie

$85.75

-2.35 (-2.67%)

14:18
11/21/18
11/21
14:18
11/21/18
14:18
Hot Stocks
Roche announces FDA grants accelerated approval for Venclexta combo »

Roche (RHHBY) announced…

RHHBY

Roche

$0.00

(0.00%)

ABBV

AbbVie

$85.75

-2.35 (-2.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/21/18
11/21
14:17
11/21/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

, RHHBY

Roche

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Hot Stocks
AbbVie says FDA grants accelerated approval to Venclexta-azacitidine combo »

AbbVie (ABBV) announced…

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$54.99

1.4 (2.61%)

14:15
11/21/18
11/21
14:15
11/21/18
14:15
Periodicals
Martin Sorrell to poach senior executive from WPP, Sky News reports »

Martin Sorrell is to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.